首页 | 本学科首页   官方微博 | 高级检索  
     


Management of diabetic complications: A chemical constituents based approach
Authors:Randhir Singh  Navpreet KaurLalit Kishore  Girish Kumar Gupta
Affiliation:Maharishi Markandeshwar College of Pharmacy, Maharishi Markandeshwar University, Mullana-Ambala, Haryana 133207, India
Abstract:

Ethnopharmacological relevance

Long term hyperglycemia leads to development of complications associated with diabetes. Diabetic complications are now a global health problem without effective therapeutic approach. Hyperglycemia and oxidative stress are important components for the development of diabetic complications. Over the past few decades, herbal medicines have attracted much attention as potential therapeutic agents in the prevention and treatment of diabetic complications due to their multiple targets and less toxic side effects. This review aims to assess the current available knowledge of medicinal herbs for attenuation and management of diabetic complications and their underlying mechanisms.

Material and methods

Bibliographic investigation was carried out by scrutinizing classical text books and peer reviewed papers, consulting worldwide accepted scientific databases (SCOPUS, PUBMED, SCIELO, NISCAIR, Google Scholar) to retrieve available published literature. The inclusion criteria for the selection of plants were based upon all medicinal herbs and their active compounds with attributed potentials in relieving diabetic complications. Moreover, plants which have potential effect in ameliorating oxidative stress in diabetic animals have been included.

Results

Overall, 238 articles were reviewed for plant literature and out of the reviewed literature, 127 articles were selected for the study. Various medicinal plants/plant extracts containing flavonoids, alkaloids, phenolic compounds, terpenoids, saponins and phytosterol type chemical constituents were found to be effective in the management of diabetic complications. This effect might be attributed to amelioration of persistent hyperglycemia, oxidative stress and modulation of various metabolic pathways involved in the pathogenesis of diabetic complications.

Conclusion

Screening chemical candidate from herbal medicine might be a promising approach for new drug discovery to treat the diabetic complications. There is still a dire need to explore the mechanism of action of various plant extracts and their toxicity profile and to determine their role in therapy of diabetic complications. Moreover, a perfect rodent model which completely mimics human diabetic complications should be developed.
Keywords:AGE, advanced glycation end products   BB rats, BioBreeding rats   BB/Wor rats, BioBreeding/Worcester rats   BBZDR/Wor rats, BioBreeding Zucker Diabetic rats   b.d., twice daily dose   b.w., Body weight   DAG, diacyl glycerol   DPN, diabetic peripheral neuropathy   DRG, dorsal root ganglion   FOS, fructooligosaccharides   G-6-P, glucose-6-phosphate   GK rats, Goto-Kakizaki rats   GLP-1, glucagon like peptide-1   GPx, glutathione peroxidase   GSH, glutathione   HbA1c, glycosylated hemoglobin A1c   HDL, High-density lipoprotein   i.g., intragastric route   i.p., intraperitoneal injection   IGF, insulin-like growth factor   IU, international units   LBP-4, Lycium barbarum Polysaccharides-4   LDL, low-density lipoprotein   MAPK, mitogen activated protein kinase   MNCV, motor nerve conduction velocity   NCV, nerve conduction velocity   NF-κB, nuclear factor kappa B   NGF, nerve growth factor   NO, nitric oxide   NOD, non-obese diabetic mice   o.d., once daily dose   OLETF rats, Otsuka Long Evans Tokushima Fatty rats   p.o., per os (oral administration)   PKC, protein kinase C   PPAR α, peroxisome proliferators-activated receptor α   PPAR γ, peroxisome proliferators-activated receptor γ   RNS, reactive nitrogen species   ROS, reactive oxygen species   SNCV, sensory nerve conduction velocity   STZ, Streptozotocin   TBARS, thiobarbituric acid reactive substances   TGF-β, transforming growth factor-β   TNF-α, tumor necrosis factor-α   v/v, volume by volume   VEGF, vascular endothelial growth factor   w/w, weight by weight   WBN/Kob rats, Wistar Bonn/Kobori rats   ZDF rats, Zucker Diabetic Fatty rats
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号